Search clinical trials for: Pi3K
Total 262 results
-
PfizerTerminatedAdvanced CancerItaly, United States, Canada, Spain
-
Novartis PharmaceuticalsCompletedPI3K Pathway Activated TumorsUnited States
-
GlaxoSmithKlineCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Recurrent Non-Hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular LymphomaUnited States, Belgium, Germany, France, Italy, Korea, Republic of, Spain, Turkey
-
Novartis PharmaceuticalsTerminatedCancer | Solid Tumor | Advanced Solid TumorJapan
-
EMD SeronoCompletedSolid TumorUnited States
-
Novartis PharmaceuticalsTerminatedSquamous Non-small Cell Lung CancerGermany, Spain, Korea, Republic of, Belgium, Italy, United States, France, Sweden
-
National Cancer Institute (NCI)WithdrawnEstrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands
-
Cascadian Therapeutics Inc.Completed
-
Cascadian Therapeutics Inc.Completed
-
Cascadian Therapeutics Inc.CompletedNon Small Cell Lung Cancer (NSCLC) | Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Canada
-
Cascadian Therapeutics Inc.CompletedIncurable Metastatic Colorectal Carcinoma | Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckUnited States, Canada
-
Emory UniversityNovartis PharmaceuticalsCompletedLung Cancer | Solid TumorsUnited States
-
University of California, DavisNovartisCompletedUnspecified Adult Solid Tumor, Protocol Specific | Extensive Stage Small Cell Lung CancerUnited States
-
Rhizen Pharmaceuticals SACompleted
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedSolid Tumor | Tumor | Malignant LymphomaUnited States
-
BayerCompleted
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
Zenyaku Kogyo Co., Ltd.Completed
-
Institut Paoli-CalmettesSuspended
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, France, Taiwan, Hungary, Germany, Singapore, Austria, Netherlands, Australia, Russian Federation, Spain, Canada, Israel, Japan, Korea, Republic of, Italy, United States, United Kingdom, Brazil, Hong Kong, Czech Republic, South...
-
EMD SeronoSanofiCompletedMelanoma | Breast Cancer | Colorectal Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Italy, Spain
-
Genentech, Inc.Completed
-
AmgenCompletedLymphoma | Leukemia | Cancer | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Hematologic Malignancies | Diffuse Large Cell Lymphoma | Oncology | Tumors | T Cell Lymphoma | Oncology Patients | Hematology | Low Grade LymphomaUnited States
-
AbbVieInfinity Pharmaceuticals, Inc.Completed
-
Verastem, Inc.TerminatedLymphoma | Metastatic Cancer | Non Hematologic CancersUnited States, United Kingdom
-
Washington University School of MedicineNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
Dana-Farber Cancer InstituteGilead SciencesTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Array BioPharmaTerminatedMelanomaCanada, Spain, Australia, Switzerland, Germany, United States
-
Genentech, Inc.Terminated
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung Cancer, Solid CancersUnited States, Netherlands
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited Kingdom
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerUnited States, France, Netherlands
-
M.D. Anderson Cancer CenterNovartisCompleted
-
Hospices Civils de LyonUnknown
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterTerminatedAdvanced CancersUnited States
-
AbbVieInfinity Pharmaceuticals, Inc.WithdrawnChronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Small Lymphocytic LymphomaUnited States
-
Rhizen Pharmaceuticals SACompletedLymphoma, B-Cell | T-Cell LymphomaFrance, Italy
-
Gilead SciencesCompletedLymphoid MalignanciesNetherlands
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerFrance, Italy, United Kingdom, Hungary, Belgium, Canada, Spain, Germany, Singapore, Netherlands, Thailand, United States, Turkey, Argentina, Brazil, Hong Kong, Japan, Taiwan
-
Medical Research CouncilMerck Sharp & Dohme LLC; Aarhus University Hospital; NCRI Clinical Studies Groups and other collaboratorsUnknownGlioblastomaUnited States, Italy, Belgium, Germany, Poland, Russian Federation, Spain, Switzerland, Ukraine, United Kingdom
-
Gilead SciencesTerminatedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Zenyaku Kogyo Co., Ltd.Completed